Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Guelph

$837,675.00

Understanding how the miR-200 family prevents tumor initiation and impairs tumor growth

EF 2018-19

Résumé
MicroRNAs are a type of RNA that can regulate the production of proteins in cells and a number of microRNAs have been implicated in regulating tumor development and progression. We have found that one family of microRNAs known as the miR-200 family can inhibit the growth of mammary tumors and even prevent their development. Using a number of molecular techniques, we will identify the cellular targets of the miR-200 family using transgenic animal models and human and mouse mammary tumor cell lines as well as tumors from breast cancer patients to understand the mechanisms through which the miR-200 family act as anti-cancer agents. We will also test whether the injection of synthetic miR-200 family members can prevent mammary tumor development or inhibit mammary tumor growth. Since microRNAs are normally found in cells, their administration might be less toxic than chemotherapy or radiation therapy.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
388483
Name
Moorehead Roger A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics 2
Projecttitle
Understanding how the miR-200 family prevents tumor initiation and impairs tumor growth
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$837,675
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Breast Cancer; Mammary Tumorigenesis; Micrornas; Transgenic Mouse Models; Tumor Dormancy; Tumor Prevention
Abstract
MicroRNAs are a type of RNA that can regulate the production of proteins in cells and a number of microRNAs have been implicated in regulating tumor development and progression. We have found that one family of microRNAs known as the miR-200 family can inhibit the growth of mammary tumors and even prevent their development. Using a number of molecular techniques, we will identify the cellular targets of the miR-200 family using transgenic animal models and human and mouse mammary tumor cell lines as well as tumors from breast cancer patients to understand the mechanisms through which the miR-200 family act as anti-cancer agents. We will also test whether the injection of synthetic miR-200 family members can prevent mammary tumor development or inhibit mammary tumor growth. Since microRNAs are normally found in cells, their administration might be less toxic than chemotherapy or radiation therapy.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Moorehead, Roger A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $837,675~ $0~